0:000:00
<p>Dr. John Sweetenham shares highlights from Day 3 of the 2025 ASCO Annual Meeting, including new research for the treatment of advanced renal cell carcinoma and 2 studies on novel approaches in non-small cell lung cancer.</p> <h2>Transcript</h2> <p class="MsoNormal"><strong><span style= "font-family: 'Calibri',sans-serif;">Dr. John Sweetenham:</span></strong> <span style= "font-family: 'Calibri',sans-serif;">Hello, I'm Dr. John Sweetenham, the host of the <em>ASCO Daily News</em> Podcast, with my takeaways on selected abstracts from Day 3 of the 2025 ASCO Annual Meeting. Today's selection features studies addressing the treatment of advanced renal cell carcinoma and 2 studies exploring novel approaches in non-small cell lung cancer. My disclosures are available in the transcript of this episode.</span></p> <p class="MsoNormal"><span style= "font-family: 'Calibri',sans-serif;">The first abstract is number</span> <a href= "https://meetings.asco.org/abstracts-presentations/252914" targe...